Sygnature Discovery
Sygnature Discovery is a leading United Kingdom-based provider of integrated drug discovery services to the global pharmaceutical industry. Key areas of expertise include medicinal and synthetic chemistry, computational chemistry and bioscience. Sygnature´s team of more than 50 industry-experienced scientists add considerable value to our clients´ programmes by undertaking key elements of the drug discovery process, such as hit finding, hit-to-lead, lead optimisation and complete integrated drug discovery projects.
Services on offer at Sygnature include:
- Medicinal Chemistry
- Synthetic Chemistry
- Computational Chemistry
- Bioscience (in vitro biology and screening)
- Arrays and Libraries
- Process and Scale-up Chemistry
- ADME/Toxicology (via a strategic alliance with Cyprotex Discovery)
Dr Paul Clewlow
